The impact of moderate to severe osteoarthritis on the physical performance and quality of life: a cross-sectional study in Greek patients (PONOS study)

[1]  Jeffrey S. Brown,et al.  Patient characteristics, pain treatment patterns, and incidence of total joint replacement in a US population with osteoarthritis , 2022, BMC Musculoskeletal Disorders.

[2]  B. Wrona,et al.  An Observational Retrospective Matched Cohort Study of Healthcare Resource Utilisation and Costs in UK Patients with Moderate to Severe Osteoarthritis Pain , 2022, Rheumatology and Therapy.

[3]  Qiang Liu,et al.  Prevalence Trends of Site‐Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 2019 , 2022, Arthritis & rheumatology.

[4]  E. Eisenberg,et al.  Prevalence and Incidence of Osteoarthritis: A Population-Based Retrospective Cohort Study , 2021, Journal of clinical medicine.

[5]  G. Colombo,et al.  Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy , 2021, Therapeutics and clinical risk management.

[6]  A. Sicras-Mainar,et al.  Disease Burden and Costs in Moderate-to-Severe Chronic Osteoarthritis Pain Refractory to Standard of Care: Ancillary Analysis of the OPIOIDS Real-World Study , 2021, Rheumatology and Therapy.

[7]  C. Coupland,et al.  Comorbidities in Osteoarthritis: A Systematic Review and Meta‐Analysis of Observational Studies , 2020, Arthritis care & research.

[8]  P. Paradowski,et al.  Polish adaptation and validation of the hip disability and osteoarthritis outcome score (HOOS) in osteoarthritis patients undergoing total hip replacement , 2020, Health and Quality of Life Outcomes.

[9]  N. Pyrsopoulos,et al.  Liver injury induced by paracetamol and challenges associated with intentional and unintentional use , 2020, World journal of hepatology.

[10]  A. Gelber,et al.  Osteoarthritis , 2020, Annals of Internal Medicine.

[11]  G. Guyatt,et al.  2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee , 2020, Arthritis care & research.

[12]  G. Collins,et al.  Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017 , 2019, Annals of the Rheumatic Diseases.

[13]  L. Lix,et al.  Existing comorbidities in people with osteoarthritis: a retrospective analysis of a population-based cohort in Alberta, Canada , 2019, BMJ Open.

[14]  J H Abbott,et al.  OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. , 2019, Osteoarthritis and cartilage.

[15]  F. Miralles-Muñoz,et al.  Validation of the Spanish Version of the Knee Injury and Osteoarthritis Outcome Score (KOOS) for Elderly Patients With Total Knee Replacement , 2019, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[16]  C. Cooper,et al.  An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). , 2019, Seminars in arthritis and rheumatism.

[17]  C. Cooper,et al.  Safety of Opioids in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis , 2019, Drugs & Aging.

[18]  R. Rizzoli,et al.  Safety of Paracetamol in Osteoarthritis: What Does the Literature Say? , 2019, Drugs & Aging.

[19]  J. Martín-Fernández,et al.  Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness , 2018, Quality of Life Research.

[20]  M. Torre,et al.  Cross-cultural adaptation and validation of the Italian version of the Hip disability and Osteoarthritis Outcome Score (HOOS) , 2018, Health and Quality of Life Outcomes.

[21]  D. Hunter,et al.  Too much opioid, too much harm. , 2017, Osteoarthritis and cartilage.

[22]  Sabina Zambon,et al.  Role of Osteoarthritis, Comorbidity, and Pain in Determining Functional Limitations in Older Populations: European Project on Osteoarthritis , 2015, Arthritis care & research.

[23]  J. Protheroe,et al.  Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis. , 2015, Osteoarthritis and cartilage.

[24]  M. Ferreira,et al.  Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials , 2015, BMJ : British Medical Journal.

[25]  S. Kingsbury,et al.  Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries. , 2014, Rheumatology.

[26]  M. Hochberg,et al.  How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the Osteoarthritis Initiative , 2013, Arthritis Research & Therapy.

[27]  P. Emery,et al.  Therapy Switching, Augmentation, and Discontinuation in Patients with Osteoarthritis and Chronic Low Back Pain , 2012, Pain practice : the official journal of World Institute of Pain.

[28]  Pradeep Suri,et al.  Epidemiology of Osteoarthritis and Associated Comorbidities , 2012, PM & R : the journal of injury, function, and rehabilitation.

[29]  Fredrik Granath,et al.  Health-related quality of life (EQ-5D) before and after orthopedic surgery , 2011, Acta orthopaedica.

[30]  A. Sadosky,et al.  Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis , 2011, Journal of medical economics.

[31]  F. Guillemin,et al.  Cross-cultural adaptation and validation of the French version of the Hip disability and Osteoarthritis Outcome Score (HOOS) in hip osteoarthritis patients. , 2010, Osteoarthritis and cartilage.

[32]  F. Guillemin,et al.  Cross-cultural adaptation and validation of the French version of the Knee injury and Osteoarthritis Outcome Score (KOOS) in knee osteoarthritis patients. , 2008, Osteoarthritis and cartilage.

[33]  S. Aslanidis,et al.  Prevalence of symptomatic knee, hand, and hip osteoarthritis in Greece. The ESORDIG study. , 2006, The Journal of rheumatology.

[34]  M. Klässbo,et al.  Hip disability and osteoarthritis outcome scoreAn extension of the Western Ontario and McMaster Universities Osteoarthritis Index , 2003, Scandinavian journal of rheumatology.

[35]  E M Badley,et al.  Differences between men and women in the rate of use of hip and knee arthroplasty. , 2000, The New England journal of medicine.

[36]  B. Beynnon,et al.  Knee Injury and Osteoarthritis Outcome Score (KOOS)--development of a self-administered outcome measure. , 1998, The Journal of orthopaedic and sports physical therapy.

[37]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.

[38]  C. Goldsmith,et al.  Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. , 1988, The Journal of rheumatology.

[39]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..